794 related articles for article (PubMed ID: 27133009)
21. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
[TBL] [Abstract][Full Text] [Related]
22. The potential for less radical surgery in women with stage IA2-IB1 cervical cancer.
Bai H; Yuan F; Wang H; Chen J; Cui Q; Shen K
Int J Gynaecol Obstet; 2015 Sep; 130(3):235-40. PubMed ID: 26070225
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
Xie X; Song K; Cui B; Jiang J; Yang X; Kong B
Int J Clin Oncol; 2018 Jun; 23(3):522-531. PubMed ID: 29299705
[TBL] [Abstract][Full Text] [Related]
24. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
[TBL] [Abstract][Full Text] [Related]
26. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
[TBL] [Abstract][Full Text] [Related]
27. Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.
Nanthamongkolkul K; Hanprasertpong J
Oncol Res Treat; 2018; 41(4):194-198. PubMed ID: 29562222
[TBL] [Abstract][Full Text] [Related]
28. Risk of ovarian recurrence after ovarian conservation in early-stage cervical cancer treated with radical surgery: A propensity match analysis.
Bizzarri N; Pedone Anchora L; Kucukmetin A; Ratnavelu N; Korompelis P; Fedele C; Bruno M; Di Fiore GLM; Fagotti A; Fanfani F; Scambia G; Ferrandina G
Eur J Surg Oncol; 2021 Aug; 47(8):2158-2165. PubMed ID: 33895023
[TBL] [Abstract][Full Text] [Related]
29. Parametrial involvement in women with low-risk, early-stage cervical cancer.
Vanichtantikul A; Tantbirojn P; Manchana T
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27704641
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Lin HH; Cheng WF; Chan KW; Chang DY; Chen CK; Huang SC
Obstet Gynecol; 1996 Aug; 88(2):274-9. PubMed ID: 8692515
[TBL] [Abstract][Full Text] [Related]
31. What is the risk for parametrial involvement in women with early-stage cervical cancer with tumour <20 mm and with negative sentinel lymph nodes?
Klat J; Sevcik L; Simetka O; Graf P; Dvorackova J; Kraft O
Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):540-4. PubMed ID: 23216324
[TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
33. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
34. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy.
Yanaranop M; Sathapornteera N; Nakrangsee S
J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S87-95. PubMed ID: 25509701
[TBL] [Abstract][Full Text] [Related]
35. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
[TBL] [Abstract][Full Text] [Related]
36. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
[TBL] [Abstract][Full Text] [Related]
37. Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis.
Huang L; Zheng M; Liu JH; Xiong Y; Ding H; Tang L; Wang HY
Chin J Cancer; 2010 Apr; 29(4):431-5. PubMed ID: 20346221
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
[TBL] [Abstract][Full Text] [Related]
39. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
40. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]